Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to investigate the multi-omics characterization early-stage lung cancer exhibiting distinct phenotypes including lung cancer associated with cystic airspaces, multiple primary lung cancers, and so on. The main questions it aims to answer are: * What are the differences in pathogenesis of non-small cell lung cancer with different phenotypes explored by multi-omics? * Whether differential genes lead to potential prognostic models and therapeutic targets? Participants will be followed up after surgery to answer prognosis: whether they have recurred, and the time to recurrence.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci w wieku 18-75 lat.
- •Stan ogólny dobry (skala ECOG 0-1).
- •Rak płuca (NSCLC) potwierdzony badaniem i w początkowym stadium (I-II).
- •Współpraca z badaczami i zgoda rodziny na obserwację stanu pacjenta po leczeniu.
- •Zrozumienie i świadome podpisanie zgody na udział w badaniu.
- •Wykrycie mnogich lub pojedynczych raków płuca według kryteriów lekarskich.
- •Zmiany w obrazie tomografii komputerowej sugerujące obecność jam powietrznych w raku płuca.
✗ Disqualifies
- •Historia innych nowotworów lub jednoczesne występowanie innych chorób nowotworowych.
- •Wcześniejsze leczenie przeciwnowotworowe (chemioterapia, radioterapia, terapie celowane).
- •Niechęć do udziału w badaniu.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Locations (1)
The Second Xiangya Hospital of Central South University
Changsha, China
Trial contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.